HomeAI · summaries
Storia in 20 fonti
Guerra por la obesidad: Novo Nordisk (Ozempic) demanda a Eli Lilly por publicidad engañosa
La farmacéutica danesa acusa a su rival estadounidense de utilizar estudios desactualizados para promocionar sus alternativas Zepbound y Mounjaro
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
Ozempic Maker Novo Nordisk Sues Eli Lilly For Deceptive Advertising
The lawsuit, filed in federal court Tuesday, accuses Eli Lilly of using outdated data in advertising campaigns.
- ·
biopharmadive.com
Novo sues Lilly, alleging ‘misleading’ advertising of obesity drugs
The lawsuit follows a cease-and-desist request and argues Lilly is using “deceptive” ads to claim its GLP-1 products are broadly superior to Novo’s medicines. Lilly countered that…
